ロング

LGVN - another short squeeze leg up ahead - 49% short flaot

アップデート済

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

This is a high risk idea - keep this in mind!

Short float: 49%
Shares float 4.4M
Borrow Fee: 625%

Passive stake of 676'229 shares on Friday , July 26

Breakout Zone: $4.0

Action: If the stock breaks above this area with strong volume, it might signal a continuation of the upward trend.

Overall Market Sentiment:
Currently, the market seems to be in a correction phase. It’s crucial to consider this sentiment when making trading decisions.

Resistance Points:

$4.00
$5.40
$6.40

Surpassing these levels could signal a positive trend. Consider taking profits at these stages to realize gains.

Trading Strategy:

Take Profit (TP): Set a target at $10.00 or even $15.00 is possible.

Stop Loss (SL): Set at under $2.50 to mitigate potential losses.

Chart Analysis:
Please refer to the attached chart for detailed analysis of price trends and movements.

Trading Advisory:
Exercise caution and consider market conditions and your own risk tolerance when trading. It's advisable to conduct comprehensive research or consult with a financial advisor before engaging in trading activities.

Disclaimer: This content is for informational purposes only and should not be considered financial advice.

トレード終了: ストップロスに到達

SL hit